Clinical significance of miR-221 and its inverse correlation with p27 Kip1 in hepatocellular carcinoma

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3029-3035

  Fu, Xinhui ^a   Wang, Qian ^a   Chen, Jingsong ^a   Huang, Xiaohui ^a   Chen, Xilin ^a   Cao, Liangqi ^a   Tan, Haoxiang ^a   Li, Wen ^a   Zhang, Longjuan ^a   Bi, Jiong ^a   Su, Qiao ^a   Chen, Lianzhou ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

HCC; In situ hybridization; miR 221; p27Kip1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MICRORNA 221; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 80052433665     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-9969-5     Document Type: Article

References (18)

1. Mazzanti R, Gramantieri L, Bolondi L (2008) Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 29:130-143 (Pubitemid 351312220)
2. Edamoto Y, Hara A, Biernat W et al (2003) Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 106:334-341 (Pubitemid 36870393)
3. Schratt GM, Tuebing F, Nigh EA et al (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289 (Pubitemid 43128846)
4. Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-838 (Pubitemid 40839735)
5. Huang XH, Wang Q, Chen JS et al (2009) Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 39:786-794
6. Visone R, Russo L, Pallante P et al (2007) MicroRNAs (miR)- 221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791-798 (Pubitemid 350074067)
7. le Sage C, Nagel R, Egan DA et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708 (Pubitemid 47236875)
8. Galardi S, Mercatelli N, Giorda E et al (2007) miR-221 and miR- 222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282:23716-23724 (Pubitemid 47311902)
9. Fornari F, Gramantieri L, Ferracin M et al (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651-5661
10. Koff A (2006) How to decrease p27Kip1 levels during tumor development. Cancer Cell 9:75-76 (Pubitemid 43202657)
11. Sheahan S, Bellamy CO, Dunbar DR et al (2007) Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. BMC Cancer 7:215
12. Enright AJ, John B, Gaul U et al (2003) MicroRNA targets in Drosophila. Genome Biol 5:R1
13. Krek A, Grun D, Poy MN et al (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500 (Pubitemid 40617277)
14. Chen JS, Wang Q, Fu XH et al (2009) Involvement of PI3 K/ PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 39:177-186
15. Chibazakura T, McGrew SG, Cooper JA et al (2004) Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc Natl Acad Sci USA 101:4465-4470 (Pubitemid 38437434)
16. Benetti A, Berenzi A, Gambarotti M et al (2008) Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res 68:8626-8634
17. Yamada Y, Mori H (2003) Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24:1015-1019 (Pubitemid 36827253)
18. Gorgoulis VG, Vassiliou LV, Karakaidos P et al (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913 3 (Pubitemid 40559004)